Association between three single nucleotide polymorphisms in eotaxin (CCL 11) gene, hexanucleotide repetition upstream, severity and course of coronary atherosclerosis

Journal of Applied Genetics

Volumn 53, Issue 3, 2012, Pages 271-278

  Machal J ^a   Vasku A ^a   Kincl, V ^b   Hlavna, M ^a   Bartakova V ^a   Jurajda, M ^a   Meluzin J ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Atherosclerosis; Coronary artery disease; Eotaxin gene; Inflammation; SCYA11 polymorphism

Indexed keywords

EOTAXIN; GLYCYLALANYLALANYLGLYCYLGLYCYLALANINE; NUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; EXON; FEMALE; GENE SEQUENCE; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS;

AGED; BASE SEQUENCE; BLOOD VESSELS; CASE-CONTROL STUDIES; CHEMOKINE CCL11; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEOTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; REPETITIVE SEQUENCES, NUCLEIC ACID;

ANGINA;

EID: 84864386595     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-012-0104-2     Document Type: Article

References (40)

1. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A (2011) Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 969-979.
2. Ardigo D, Assimes TL, Fortmann SP, Go AS, Hlatky M, Hytopoulos E, Iribarren C, Tsao PS, Tabibiazar R, Quertermous T, Investigators A (2007) Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics 31: 402-409.
3. Batra J, Rajpoot R, Ahluwalia J, Devarapu SK, Sharma SK, Dinda AK, Ghosh B (2007) A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels. J Med Genet 44: 397-403.
4. Buzbas EO, Joyce P, Abdo Z (2009) Estimation of selection intensity under overdominance by Bayesian methods. Stat Appl Genet Mol Biol 8: Article32.
5. Canouï-Poitrine F, Luc G, Mallat Z, Machez E, Bingham A, Ferrieres J, Ruidavets JB, Montaye M, Yarnell J, Haas B, Arveiler D, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P, Empana JP, P. S. Group (2011) Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology 77: 1165-1173.
6. Chang HS, Kim JS, Lee JH, Cho JI, Rhim TY, Uh ST, Park BL, Chung IY, Park CS, Shin HD (2005) A single nucleotide polymorphism on the promoter of eotaxin1 associates with its mRNA expression and asthma phenotypes. J Immunol 174: 1525-1531.
7. Choi SY, Mintz GS (2010) What have we learned about plaque rupture in acute coronary syndromes? Curr Cardiol Rep 12: 338-343.
8. Economou E, Tousoulis D, Katinioti A, Stefanadis C, Trikas A, Pitsavos C, Tentolouris C, Toutouza MG, Toutouzas P (2001) Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty. Int J Cardiol 80: 55-60.
9. Emanuele E, Falcone C, D'Angelo A, Minoretti P, Buzzi MP, Bertona M, Geroldi D (2006) Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis 186: 140-145.
10. Fulop T, Tessier D, Carpentier A (2006) The metabolic syndrome. Pathol Biol (Paris) 54: 375-386.
11. Garcia-Zepeda EA, Rothenberg ME, Weremowicz S, Sarafi MN, Morton CC, Luster AD (1997) Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics 41: 471-476.
12. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ (1993) The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 197: 1167-1172.
13. Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GH, Libby P, Lee RT (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102: 2185-2189.
14. Hampel KJ, Ashley C, Lee JS (1994) Kilobase-range communication between polypurine. polypyrimidine tracts in linear plasmids mediated by triplex formation: a braided knot between two linear duplexes. Biochemistry 33: 5674-5681.
15. Hansson GK (1993) Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 69: S38-S41.
16. Hao H, Gabbiani G, Bochaton-Piallat ML (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23: 1510-1520.
17. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ (2004) Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 110: 928-933.
18. Kaehler J, Tuleweit A, Steven D, Krempl T, Haar A, Carstensen M, Koester R, Terres W, Meinertz T (2006) Association between eotaxin (CCL11), C-reactive protein, and antimicrobial antibodies in patients undergoing coronary angioplasty. J Investig Med 54: 446-454.
19. Kodali RB, Kim WJ, Galaria II, Miller C, Schecter AD, Lira SA, Taubman MB (2004) CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration. Arterioscler Thromb Vasc Biol 24: 1211-1216.
20. Kojima K (1959) Role of epistasis and overdominance in stability of equilibria with selection. Proc Natl Acad Sci U S A 45: 984-989.
21. Little PJ, Chait A, Bobik A (2011) Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacol Ther 131: 255-268.
22. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, Kay AB (2002) Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 169: 2712-2718.
23. Miyamasu M, Sekiya T, Ohta K, Ra C, Yoshie O, Yamamoto K, Tsuchiya N, Tokunaga K, Hirai K (2001) Variations in the human CC chemokine eotaxin gene. Genes Immun 2: 461-463.
24. Mosedale DE, Smith DJ, Aitken S, Schofield PM, Clarke SC, McNab D, Goddard H, Gale CR, Martyn CN, Bethell HW, Barnard C, Hayns S, Nugent C, Panicker A, Grainger DJ (2005) Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction. Atherosclerosis 183: 268-274.
25. Munro JM, Cotran RS (1988) The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 58: 249-261.
26. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez-Ramos JC, Mackay CR (1996) Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97: 604-612.
27. Raaz-Schrauder D, Klinghammer L, Baum C, Frank T, Lewczuk P, Achenbach S, Cicha I, Stumpf C, Wiltfang J, Kornhuber J, Daniel WG, Garlichs CD (2012) Association of systemic inflammation markers with the presence and extent of coronary artery calcification. Cytokine 57: 251-257.
28. Raby BA, van Steen K, Lazarus R, Celedón JC, Silverman EK, Weiss ST (2006) Eotaxin polymorphisms and serum total IgE levels in children with asthma. J Allergy Clin Immunol 117: 298-305.
29. Rigoli L, Caminiti L, Di Bella C, Procopio V, Cuppari C, Vita D, Barberio G, Salpietro C, Pajno GB (2008) Investigation of the eotaxin gene -426C-->T, -384A-->G and 67G-->a single-nucleotide polymorphisms and atopic dermatitis in Italian children using family-based association methods. Clin Exp Dermatol 33: 316-321.
30. Rippe K, Fritsch V, Westhof E, Jovin TM (1992) Alternating d(G-A) sequences form a parallel-stranded DNA homoduplex. EMBO J 11: 3777-3786.
31. Rosner SA, Ridker PM, Zee RY, Cook NR (2005) Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician's Health Study. Hum Genet 118: 287-294.
32. Sallusto F, Mackay CR, Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
33. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Suenram CA, Rozek MM (1985) Atherosclerosis as an inflammatory process. The roles of the monocyte-macrophage. Ann N Y Acad Sci 454: 115-120.
34. Schwartz SM, deBlois D, O'Brien ER (1995) The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465.
35. Sheikine Y, Olsen B, Gharizadeh B, Jatta K, Tornvall P, Ghaderi M (2006) Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls. Atherosclerosis 189: 458-463.
36. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
37. WHO (2011) World Health Organization - Global atlas on CVD prevention and control, available 16/03/2012 on URL: http://whqlibdoc. who. int/publications/2011/9789241564373_eng. pdf.
38. Wyss CA, Neidhart M, Altwegg L, Spanaus KS, Yonekawa K, Wischnewsky MB, Corti R, Kucher N, Roffi M, Eberli FR, Amann-Vesti B, Gay S, von Eckardstein A, Lüscher TF, Maier W (2010) Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J 31: 1457-1469.
39. Yamada H, Hirai K, Miyamasu M, Iikura M, Misaki Y, Shoji S, Takaishi T, Kasahara T, Morita Y, Ito K (1997) Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun 231: 365-368.
40. Zee RY, Cook NR, Cheng S, Erlich HA, Lindpaintner K, Lee RT, Ridker PM (2004) Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction. Atherosclerosis 175: 91-94.